Biedka S, Yablonska S, Peng X, Alkam D, Hartoyo M, VanEvery H
J Proteome Res. 2025; 24(2):795-812.
PMID: 39814365
PMC: 11812086.
DOI: 10.1021/acs.jproteome.4c00837.
Allameen N, Ramos-Lisbona A, Wedderburn L, Lundberg I, Isenberg D
Nat Rev Rheumatol. 2024; 21(1):46-62.
PMID: 39609638
DOI: 10.1038/s41584-024-01188-4.
Wilhelm S, Kakadia J, Beharry A, Kenana R, Hoffman K, ODonoghue P
Nucleic Acids Res. 2024; 52(22):14043-14060.
PMID: 39530218
PMC: 11662652.
DOI: 10.1093/nar/gkae996.
Musai J, Mammen A, Pinal-Fernandez I
Curr Rheumatol Rep. 2024; 26(12):421-430.
PMID: 39316320
PMC: 11527972.
DOI: 10.1007/s11926-024-01164-7.
Pinal-Fernandez I, Munoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J
Ann Rheum Dis. 2024; 83(11):1549-1560.
PMID: 38902010
PMC: 11493519.
DOI: 10.1136/ard-2024-225773.
Pathogenic autoantibody internalization in myositis.
Pinal-Fernandez I, Munoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J
medRxiv. 2024; .
PMID: 38313303
PMC: 10836124.
DOI: 10.1101/2024.01.15.24301339.
Connective tissue disease as a challenge in heart failure: Three case reports.
Liu K, Li X, Li D
Medicine (Baltimore). 2024; 103(3):e36885.
PMID: 38241553
PMC: 10798719.
DOI: 10.1097/MD.0000000000036885.
Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.
Van Gompel E, Demirdal D, Fernandes-Cerqueira C, Horuluoglu B, Galindo-Feria A, Wigren E
Rheumatology (Oxford). 2023; 63(5):1466-1473.
PMID: 37572295
PMC: 11065437.
DOI: 10.1093/rheumatology/kead400.
Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy.
Oka H, Sumitomo S, Shimizu H, Kanamori M, Murata S, Yamashita D
Intern Med. 2023; 62(18):2747-2751.
PMID: 36754403
PMC: 10569925.
DOI: 10.2169/internalmedicine.1275-22.
Mechanistic perspectives on anti-aminoacyl-tRNA synthetase syndrome.
Kanaji S, Chen W, Morodomi Y, Shapiro R, Kanaji T, Yang X
Trends Biochem Sci. 2022; 48(3):288-302.
PMID: 36280495
PMC: 9974581.
DOI: 10.1016/j.tibs.2022.09.011.
Severe digital ischemia as an unrecognized manifestation in patients with antisynthetase autoantibodies: Case series and systematic literature review.
Yoshida A, Gono T, Okazaki Y, Shirai Y, Takeno M, Kuwana M
J Scleroderma Relat Disord. 2022; 7(3):204-216.
PMID: 36211206
PMC: 9537703.
DOI: 10.1177/23971983221090857.
Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond.
Galindo-Feria A, Notarnicola A, Lundberg I, Horuluoglu B
Front Immunol. 2022; 13:866087.
PMID: 35634293
PMC: 9136399.
DOI: 10.3389/fimmu.2022.866087.
High-Dimensional Analysis Reveals Distinct Endotypes in Patients With Idiopathic Inflammatory Myopathies.
Wilfong E, Bartkowiak T, Vowell K, Westlake C, Irish J, Kendall P
Front Immunol. 2022; 13:756018.
PMID: 35371068
PMC: 8964392.
DOI: 10.3389/fimmu.2022.756018.
Myositis-Related Interstitial Lung Disease: A Respiratory Physician's Point of View.
Waseda Y
Medicina (Kaunas). 2021; 57(6).
PMID: 34200737
PMC: 8230365.
DOI: 10.3390/medicina57060599.
A Clinical Case of Polymyositis Complicated by Antisynthetase Syndrome.
Khan A, Ahmad Jr F, Rehman U, Jindal H, Harimohan H
Cureus. 2021; 13(1):e12737.
PMID: 33614339
PMC: 7883527.
DOI: 10.7759/cureus.12737.
The uniqueness of AlaRS and its human disease connections.
Zhang H, Yang X, Sun L
RNA Biol. 2020; 18(11):1501-1511.
PMID: 33317386
PMC: 8583063.
DOI: 10.1080/15476286.2020.1861803.
Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants.
Burman L, Chong Y, Duncan S, Klaus A, Rauch K, Hamel K
MAbs. 2020; 12(1):1836718.
PMID: 33131414
PMC: 7646482.
DOI: 10.1080/19420862.2020.1836718.
Auto-antibody evaluation in idiopathic interstitial pneumonia and worse survival of patients with Ro52/TRIM21auto-antibody.
Morita H, Shimizu Y, Nakamura Y, Okutomi H, Watanabe T, Yokoyama T
J Clin Biochem Nutr. 2020; 67(2):199-205.
PMID: 33041518
PMC: 7533866.
DOI: 10.3164/jcbn.20-5.
Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile.
Ramos-Martinez E, Falfan-Valencia R, Perez-Rubio G, Mejia M, Buendia-Roldan I, Gonzalez-Perez M
J Clin Med. 2020; 9(5).
PMID: 32384594
PMC: 7290669.
DOI: 10.3390/jcm9051356.
Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses.
Adams R, Fernandes-Cerqueira C, Notarnicola A, Mertsching E, Xu Z, Lo W
Cell Mol Immunol. 2019; 18(6):1463-1475.
PMID: 31797905
PMC: 8166958.
DOI: 10.1038/s41423-019-0331-0.